Delivery Order SPE2DB20D1100-SPE2DB25FC2A8
Award Date
5/8/25
Potential Completion Date
5/9/25
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,476.69 firm fixed-price contract is for the supply of the diabetes medication Mounjaro (5 mg/0.5 ml pen). The contract has a performance period through May 12, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.36 firm fixed-price contract is for the supply of the diabetes medication Mounjaro (5 mg/0.5 ml pen) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,156.88 firm fixed-price delivery order is for the drug Mounjaro 12.5 mg/0.5 ml pen, a medication used for the treatment of diabetes. The contract has an ultimate completion date of June 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,701.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the diabetes medication Mounjaro 5 mg/0.5 ml pen 0.5 ml. This is a firm fixed-price delivery order contract with a performance period ending on May 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,441.80, is for the delivery of 4,568,078,553 units of the diabetes medication Mounjaro (12.5 mg/0.5 ml pen, 0.5 ml) with a performance period through April 30, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,967,847 units of the diabetes medication Mounjaro 15 mg/0.5 ml pen. The total ceiling value of the contract is $10,936.86 with a performance period ending on April 21, 2025. This award is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,758.60, is for the supply of the diabetes medication Mounjaro 7.5 mg/0.5 ml pen. The delivery order has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,779.03 delivery order contract is for the supply of Mounjaro 2.5 mg/0.5 mL pens, a medication used to treat diabetes. The contract has a firm fixed-price pricing type and an ultimate completion date of April 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,578.00 firm fixed-price delivery order is for the supply of the diabetes medication Mounjaro (5 mg/0.5 ml pen, 0.5 ml) with an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,759.50 firm fixed-price contract is for the supply of Mounjaro 12.5 mg/0.5 ml pens, a diabetes treatment medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...